The European Medicines Agency (EMA) publishes opinions on the qualification of innovative development methods and letters of support for novel methodologies that have been shown to be promising in the context of research and development into pharmaceuticals.
View this resource Bookmark this resource
Opinions and letters of support on the qualification of novel methodologies for medicine development
Published by European Medicines Agency (EMA)ECRIN
Clinical Trials Toolkit